Why Won't depression go away? scientists scan brains for answers
NCT ID NCT03537794
First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 4 times
Summary
This study aims to understand why some people with depression don't get better with standard medications. Researchers will use brain scans to compare dopamine receptors in 45 people: those with treatment-resistant depression, those whose depression responds to treatment, and healthy volunteers. The goal is to find biological differences that could lead to better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be recruited from clinics at St. Michael's Hospital and the Centre for Addiction and Mental Health as well as from research programs at the two sites, which have ongoing MDD clinical trials where patients are required to be unmedicated prior to initiating treatment.
- Ages
-
25 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Key inclusion criteria for the MDD patients: * DSM-5 criteria for a Major Depressive Episode (MDE) within a MDD, confirmed through MINI diagnosis (Sheehan et al, 2015) * Age between 25 and 65 years * Hamilton Depression Rating Scale - 17 item (HRSD-17; Hamilton, 1960) \> 14 (moderate to severe symptoms) * Free of psychotropic medications (with the exception of SSRIs or SNRIs) for at least 5 half-lives before PET scanning per investigator discretion, after which an insignificant amount of drug is circulating through the body and accessing the brain. This determination will be based on self-report from the participant of when their last dose was. Use of benzodiazepines (except for diazepam) or sedative hypnotics (e.g. zopiclone) is allowable, but the last dose must be at least 72 hours prior to scanning. * Ability to undergo MRI scanning (absence of metal, pacemakers, etc.) * For non-resistant patients: Previous history of response to an antidepressant, in order to increase signal to noise between resistant and non-resistant patients Key inclusion criteria for the Healthy Controls: * Ages between 25 and 65 years * Ability to undergo MRI scanning (absence of metal, pacemakers, etc.) Exclusion Criteria: Key exclusion criteria for the MDD patients: * Pregnancy/lactation * Medical condition requiring immediate investigation or treatment * Recent (\< 6 months)/current history of drug abuse/dependence * Lifetime history of psychosis, other Axis I comorbidities are allowable * Use of any psychotropic use within 5 half-lives before the PET scanning, with the exception of SSRIs and SNRIs * For non-resistant patients: Failure of \> 2 antidepressant treatments of adequate dose and duration for current MDE. Key exclusion criteria for the Healthy Controls: * Pregnancy/lactation * Medical condition requiring immediate investigation or treatment * Lifetime history of any psychiatric disorder * Lifetime history of receiving an antidepressant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression - major depressive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Unity Health Toronto
RECRUITINGToronto, Ontario, M5B 1M4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new oral drug lift severe depression?
- Magnetic pulses target teen depression
- Can an antipsychotic restore feelings in people with depression?
- Can intense brain zaps lift depression? scientists track blood flow in real time
- Can brain stimulation rewire how depressed patients learn from rewards?
- Can an ancient herbal capsule boost antidepressant power?